Pages
-
-
Clinical implications of incorporating genetic and non-genetic risk factors in CanRisk-based breast cancer risk prediction
-
-
Evaluation of European-based polygenic risk score for breast cancer in Ashkenazi Jewish women in Israel
-
-
Systematic minigene-based splicing analysis and tentative clinical classification of 52 CHEK2 splice-site variants
-
-
Multi-gene panel testing and association analysis in Cypriot breast cancer cases and controls
-
-
a likelihood ratio approach for utilizing case-control data in the clinical classification of rare sequence variants
-
-
Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survival
-
-
Spectrum and frequency of germline FANCM protein-truncating variants in 44,803 European female breast cancer cases
-
-
The impact of coding germline variants on contralateral breast cancer risk and survival
-
-
FANCM missense variants and breast cancer riskn
-
-
Aggregation tests identify new gene associations with breast cancer in populations with diverse ancestry
-
-
PredictCBC-2.0: a contralateral breast cancer risk prediction model developed and validated in similar to 200,000 patients (vol 24, 69, 2022)
-
-
PredictCBC-2.0: a contralateral breast cancer risk prediction model developed and validated in similar to 200,000 patients
-
-
Long-term in vitro 2D-culture of SDHB and SDHD-related human paragangliomas and pheochromocytomas
-
-
Enhancing the BOADICEA cancer risk prediction model to incorporate new data on RAD51C, RAD51D, BARD1 updates to tumour pathology and cancer incidence
-
-
Clinical applicability of the Polygenic Risk Score for breast cancer risk prediction in familial cases
-
-
Incorporating progesterone receptor expression into the PREDICT breast prognostic model
-
-
Physical activity, sedentary time and breast cancer risk
-
-
Minigene-based splicing analysis and ACMG/AMP-based tentative classification of 56 ATM variants
-
-
Uncovering the Contribution of Moderate-Penetrance Susceptibility Genes to Breast Cancer by Whole-Exome Sequencing and Targeted Enrichment Sequencing of Candidate Genes in Women of European Ancestry
-
-
Hypothesis: Why Different Types of SDH Gene Variants Cause Divergent Tumor Phenotypes
-
-
Breast cancer risks associated with missense variants in breast cancer susceptibility genes
-
-
Genetic clinicians' confidence in BOADICEA comprehensive breast cancer risk estimates and counselees' psychosocial outcomes
-
-
Assessment of psychosocial difficulties by genetic clinicians and distress in women at high risk of breast cancer
-
-
Functional analysis identifies damaging CHEK2 missense variants associated with increased cancer risk
Pages